Skip to main content

Medical Research

Follow Medical Research in the Factlen app and get an alert when there is news. Get the app

More in Medical Research

ExplainerNeural Lineage

Fundamental 'Lineage Rule' Discovered for How Brain Cells Organize During Development

Developmental Biologists 50%AI System Architects 30%Clinical Oncologists 20%

3 sources · 115d ago

Eczema Treatment

FDA Approves Ebglyss for Atopic Dermatitis With Six-Injections-Per-Year Maintenance Dosing

Clinical Dermatologists 40%Patient Advocates 35%Market Analysts 25%

2 sources · 116d ago

ExplainerGlioblastoma Research

Novel Vitamin B12 Compound Crosses Blood-Brain Barrier to Target Glioblastoma Tumors

Oncology Researchers 47%Clinical Skeptics 35%Patient Advocates 18%

2 sources · 116d ago

Biotech M&AStrategic Acquisition

GSK Acquires Nuvalent for $10.6 Billion to Secure Next-Generation Lung Cancer Therapies

GSK Strategy Analysts 35%Precision Oncology Advocates 35%Biotech Market Observers 30%

4 sources · 116d ago

Research BriefMetastatic Breast Cancer

FDA Approves Palbociclib to Significantly Extend Progression-Free Survival in HR+/HER2+ Metastatic Breast Cancer

Clinical Oncologists 40%Breast Cancer Researchers 35%Health Economists & Payers 25%

5 sources · 116d ago

ExplainerGenomic Medicine

Large-Scale Whole Genome Sequencing Identifies Six New Cancer Risk and Resistance Genes in Landmark Study

Genomic Researchers 35%Drug Developers 35%Health Equity Advocates 29%

4 sources · 116d ago

Cell TherapyBiotech M&A

Eli Lilly Acquires Kelonia Therapeutics for $7 Billion to Revolutionize CAR-T Cell Therapy

Industry Strategists 40%Clinical Innovators 35%Market Forecasters 25%

1 sources · 116d ago

ExplainerAutoimmune Breakthrough

CAR-T Cell Therapy Resets Immune Memory by Depleting Rogue B-Cells in Lupus and MS

Clinical Researchers 40%Patient Advocates 30%Biotech Developers 30%

4 sources · 117d ago

Acromegaly

FDA Approves Paltusotine as the First Once-Daily Oral Treatment for Acromegaly

Patients & Advocacy Groups 40%Endocrinologists & Clinicians 35%Pharmaceutical Developers 25%

4 sources · 117d ago

Deep DiveGenetic Medicine

FDA-Approved Otarmeni Uses Dual AAV Vectors to Restore Hearing in Genetic Deafness

Medical Researchers 40%Deaf Culture Advocates 30%Healthcare Payers 30%

4 sources · 117d ago

Deep DiveLongevity Medicine

Major Human Trial Launches to Test Three FDA-Approved Drugs for Healthspan and New Regulatory Endpoint

Geroscience Researchers 40%Regulatory Pragmatists 35%Clinical Skeptics 25%

4 sources · 117d ago

Breast Cancer

FDA Grants Full Approval to Datopotamab Deruxtecan for Metastatic Triple-Negative Breast Cancer

Clinical Investigators 47%Regulatory Authorities 35%Industry Developers 18%

3 sources · 117d ago

ExplainerAntibiotic Resistance

FDA Approves Utebzi, the First Oral Carbapenem Antibiotic for Complicated Urinary Tract Infections

Infectious Disease Specialists 41%Antimicrobial Stewardship Advocates 35%Pharmaceutical Developers 24%

1 sources · 117d ago

ExplainerPerformance Science

Swimmer Shatters World Record at Inaugural Enhanced Games, Igniting Scientific Debate on Human Limits

Anti-Doping Traditionalists 40%Techno-Optimists 35%Sports Medical Community 25%

4 sources · 117d ago

ExplainerMedical Equity

Gene Therapy Cures Sickle Cell: The New Frontier of Medical Equity

Health Equity Advocates 40%Clinical Researchers 30%Public Payers & Policymakers 30%

3 sources · 117d ago

Muscle PreservationDrug Pipeline

The Pharmaceutical Race to Solve GLP-1 Muscle Loss: Myostatin Inhibitors Enter Phase II Trials

Biopharma Innovators 45%Metabolic Researchers 30%Clinical Skeptics 25%

5 sources · 117d ago

Sleep Apnea

Phase 3 Trial Shows AD109 Pill Targets Neuromuscular Cause of Sleep Apnea

Sleep Medicine Physicians 40%Pharmaceutical Developers 35%Patient Advocates 25%

2 sources · 118d ago

Genetic EngineeringEvidence Pack

First Base-Editing of Human Embryos Achieves Precise DNA Changes Without Chromosomal Damage

Developmental Biologists 40%Bioethics & Policy Watchdogs 35%Clinical Geneticists 25%

6 sources · 119d ago

Research BriefCell Therapy

CAR-T Cell Therapy Achieves 'Durable Remission' in Lupus and Sclerosis, Signaling Paradigm Shift for Autoimmune Disease

Immunology Researchers 40%Rheumatology Clinicians 35%Health Economists 25%

5 sources · 119d ago

ExplainerStem Cell Therapy

First Embryonic Stem Cell Trial for Huntington's Disease Aims to Replace Lost Neurons

Regenerative Medicine Researchers 40%Clinical Neurologists & Surgeons 30%Patient Advocacy Groups 30%

4 sources · 119d ago

Research BriefLongevity Science

Trial Finds GLP-1 Drugs Reduce Biological Age by 2.4 Years on GrimAge Clock

Longevity Medicine Advocates 40%Clinical Skeptics 35%Trial Investigators 25%

4 sources · 119d ago

Muscle Recovery

Macrophages Form Neuron-Like Synapses to Trigger Muscle Repair in Seconds

Immunologists & Cell Biologists 40%Sports Medicine Researchers 30%Clinical Neuromuscular Specialists 30%

3 sources · 119d ago

ExplainerPeptide Therapy

Epitalon Clears an FDA Hurdle: Clinical Evidence on Cellular Aging and Telomeres

Longevity Researchers 40%Regulatory Agencies 35%Endocrinologists 25%

6 sources · 119d ago

Deep DiveVagus Nerve

Invasive Vagus Nerve Stimulation Shows Sustained Two-Year Remission in Severe Treatment-Resistant Depression

Clinical Researchers 40%Patients & Advocates 30%Healthcare Payers 30%

3 sources · 119d ago

ExplainerPancreatic Cancer

Pan-RAS Inhibitors Nearly Double Survival in Advanced Pancreatic Cancer Trials

Clinical Oncologists 40%Research Scientists 35%Industry Analysts 25%

5 sources · 120d ago

ExplainerRNA Therapeutics

Olezarsen Targets Liver RNA to Reduce Pancreatitis in Severe Hypertriglyceridemia

Clinical Lipidologists 40%RNA Therapeutics Researchers 35%Patient Advocacy Groups 25%

3 sources · 120d ago

ExplainerAddiction Medicine

GLP-1 Drugs Curb Alcohol Consumption by Dampening the Brain's Dopamine Circuitry

Addiction Researchers 40%Clinical Psychiatrists 35%Factlen Editorial Analysis 25%

3 sources · 120d ago

Research BriefPhage Therapy

Synthetic Bacteriophages Target and Lyse Antibiotic-Resistant Superbugs

Clinical Microbiologists 41%Synthetic Biologists 35%Regulatory Experts 24%

4 sources · 120d ago

ExplainerPredictive Health

DoD's RATE Algorithm Uses Wearables to Predict Infections 48 Hours Before Symptoms

Military Readiness Planners 40%Medical Researchers 40%Privacy Advocates 20%

4 sources · 120d ago

ExplainerStructural Biology

How AlphaFold 3 Works: The AI Predicting the Molecules of Life

Computational Biologists 40%Pharmaceutical Researchers 40%Open-Source Community 20%

4 sources · 120d ago

Biotech FundingStrategic Partnership

Eli Lilly Commits $1.9 Billion to Shanghai Biotech Abbisko in AI Drug Discovery Pact

Global Pharma Executives 40%Biotech Innovators 35%Market Analysts 25%

3 sources · 120d ago

ExplainerGenetic Code

Mammalian Cells Deliberately Mistranslate RNA to Produce Stable Protein Variants

Molecular Biologists 40%Oncology Researchers 30%Proteomics Technologists 30%

4 sources · 120d ago

ExplainerNeurotechnology

Focused Ultrasound Uses Converging Sound Waves to Treat Tremor Without Incisions

Clinical Neurologists 40%Medical Device Researchers 35%Patient Advocates 25%

3 sources · 120d ago

ExplainerGene Therapy

Regenxbio's RGX-202 Trial Links Protein Expression to Preserved Mobility in Duchenne

Clinical Investigators 40%Patient Advocacy Groups 35%Regulatory Analysts 25%

3 sources · 120d ago

ExplainerBiomanufacturing

Military Distributed Biomanufacturing: Synthesizing Medicines on Demand

Biomanufacturing Innovators 40%Defense Logisticians 35%Quality Assurance Experts 25%

4 sources · 120d ago

Deep DiveNeuroprosthetics

AI-Powered Wearable Restores Natural Speech for Paralyzed Patients Without Brain Surgery

Medical Researchers 40%AI & Engineering Teams 35%Patient Advocates 25%

4 sources · 120d ago

Deep DiveAntibiotic Resistance

Scientists Uncover a 'Megacluster' of Synergistic Antibiotics Evolved by Soil Bacteria

Evolutionary Microbiologists 35%Pharmacologists 35%Infectious Disease Specialists 30%

8 sources · 120d ago

Regenerative MedicineClinical Trial Explainer

Toregem BioPharma's TRG035 Blocks USAG-1 to Stimulate Dormant Tooth Buds

Regenerative Researchers 40%Pediatric Dental Specialists 35%Clinical Skeptics 25%

2 sources · 120d ago

Bundibugyo OutbreakClinical Trial

How Scientists Are Deploying Two Experimental Drugs Against the Rare Bundibugyo Ebola Strain

Public Health Coordinators 40%Virology Researchers 35%Biopharmaceutical Developers 25%

6 sources · 119d ago

Deep DiveGenerative Biology

AI Model Achieves 'Zero-Shot' Design of Drug-Binding Proteins from Scratch

Structural Biologists 40%Translational Medicine Advocates 35%Computational Biologists 25%

4 sources · 120d ago

Medical AIIndustry Shift

AI's Medical Era Arrives: How 2026 Became the Year Algorithms Moved from Hype to Hospitals

Pharmaceutical Innovators 40%Clinical Data Scientists 30%Public Health Advocates 30%

1 sources · 120d ago

Drug DiscoveryMedical Breakthrough

First Fully AI-Designed Drug Shows Efficacy in Human Trials, Marking a Turning Point for Medicine

Biotech Optimists 45%Clinical Realists 35%R&D Strategists 20%

3 sources · 120d ago

ExplainerAI Meta-Analysis

The End of Outdated Science: How AI is Powering 'Living' Systematic Reviews

Evidence Methodologists 40%Clinical Practitioners 30%AI Developers 30%

4 sources · 120d ago

ExplainerExpansion Microscopy

A Billion-Fold Expansion Technique is Democratizing High-End Microscopy

Global Science Advocates 40%Biomedical Researchers 40%Imaging Purists 20%

3 sources · 121d ago

Medical AIClinical Breakthrough

Specialized Medical AI Models Match Human Physicians in Landmark Clinical Trials

Medical Innovators 45%Tech Industry Strategists 35%Clinical Cautious Voices 20%

2 sources · 121d ago

Research BriefCRISPR Base Editing

Custom CRISPR Base Editing for CPS1 Deficiency: Delivery Mechanisms and Clinical Data

Clinical Geneticists & Researchers 40%Regulatory & Bioethics Experts 30%Biotech Industry Analysts 30%

3 sources · 121d ago

Per page